Form 4: Alto Ingredients Director Dianne Nury Reports Future Stock Acquisition Under 10b5-1 Plan

Alto Ingredients Director Dianne S. Nury reported the future acquisition of 36,666 shares of common stock on July 9, 2025, bringing her total beneficial ownership to 217,410 shares, likely under a Rule 10b5-1 plan.

Summary

• Dianne S. Nury, a Director of Alto Ingredients, Inc. (ALTO), reported a planned acquisition of common stock.
• The transaction date for the acquisition is July 9, 2025.
• She is set to acquire 36,666 shares of Common Stock.
• The acquisition price is stated as $0 per share, indicating a grant or award rather than a cash purchase.
• Following this transaction, her direct beneficial ownership will be 217,410 shares of Common Stock.
• The transaction is indicated to be pursuant to a Rule 10b5-1 plan, which allows insiders to set up pre-planned transactions to avoid accusations of insider trading.

Sentiment

Score: 6

Explanation: The planned acquisition of shares by a director, even at a $0 price (likely a grant), generally indicates alignment of interests with shareholders and confidence in the company's future, contributing to a moderately positive sentiment.

Positives

• Increased alignment of Director Dianne S. Nury's interests with shareholders due to a planned increase in her beneficial ownership of Alto Ingredients, Inc. common stock by 36,666 shares.
• The transaction is pursuant to a Rule 10b5-1 plan, indicating a pre-scheduled, non-discretionary acquisition, which can be viewed as a structured component of compensation or long-term incentive.

Negatives

• The acquisition price of $0 indicates that this is likely a stock grant or award rather than a direct cash investment by the director, meaning no new capital is being personally invested by the director into the company through this specific transaction.

Future Outlook

The document indicates a planned future acquisition of 36,666 shares of common stock by Director Dianne S. Nury on July 9, 2025, likely under a pre-arranged Rule 10b5-1 plan.

Industry Context

This Form 4 filing details an individual insider transaction and does not provide broader industry context or trends.

Related Party Transactions

• Acquisition of 36,666 shares of common stock by Dianne S. Nury, a Director of Alto Ingredients, Inc., at a price of $0, likely as part of compensation or a grant.

Stakeholder Impact

• Shareholders: Increased alignment of director's interests with shareholders due to higher ownership, potentially signaling confidence in the company's long-term prospects.

Next Steps

• The actual acquisition of 36,666 shares by Dianne S. Nury on July 9, 2025, as reported.

Key Dates

Recommendation

Keywords

Alto Ingredients, ALTO, Form 4, insider transaction, beneficial ownership, stock acquisition, director, Dianne Nury, Rule 10b5-1